Lindbrook Capital’s BELLUS Health Inc. BLU Stock Holding History

Lindbrook Capital’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-156	Closed	-$2.3K	–	2876
2023 Q2	$2.3K	Hold	156	–	–	﹤0.01%	2103
2023 Q1	$1.12K	Hold	156	–	–	﹤0.01%	2431
2022 Q4	$1.28K	Hold	156	–	–	﹤0.01%	2405
2022 Q3	$2K	Hold	156	–	–	﹤0.01%	2191
2022 Q2	$1K	Hold	156	–	–	﹤0.01%	2438
2022 Q1	$1K	Hold	156	–	–	﹤0.01%	2438
2021 Q4	$1K	Hold	156	–	–	﹤0.01%	2039
2021 Q3	$1K	Hold	156	–	–	﹤0.01%	1821
2021 Q2	$0	Hold	156	–	–	﹤0.01%	2022
2021 Q1	$1K	Hold	156	–	–	﹤0.01%	1836
2020 Q4	$0	Hold	156	–	–	﹤0.01%	1908
2020 Q3	$0	Sell	156 -1,000	-87%	-$2.83K	﹤0.01%	1876
2020 Q2	$12K	Buy	1,156 +1,000	+641%	+$10.1K	﹤0.01%	790
2020 Q1	$2K	Hold	156	–	–	﹤0.01%	1353
2019 Q4	$1K	Buy	+156	New	+$1.07K	﹤0.01%	1470

Other funds holding BLU

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

Lindbrook Capital's BLU Position: Q3 2023 in Review

Lindbrook Capital sold out of BELLUS Health Inc. (BLU) in Q3 2023, closing a stake of 156 shares — an estimated $2.3K sold.

Lindbrook Capital first reported a position in BLU in Q4 2019 and held it in 15 quarters. The position peaked at $12K in Q2 2020. 1 fund tracked by Wall St. Rank holds BLU as of Q3 2023.

Lindbrook Capital reported no remaining BELLUS Health Inc. position as of Q3 2023 after selling out during the quarter.
Lindbrook Capital sold 156 BELLUS Health Inc. shares in Q3 2023, an estimated $2.3K.
Lindbrook Capital first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 15 quarters.
Lindbrook Capital's BELLUS Health Inc. position peaked at $12K in Q2 2020.
1 fund tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2023.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.